URGN UroGen Pharma Ltd.
Healthcare$28.89-3.31%ClosedMarket Cap: $1.41B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$42.50
Target (Median)
$42.50
Target Range
$40.00 - $45.00
Upside from current price: 47.1%
Rating Distribution
1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-07 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-31 | D. Boral Capital | maintain | Buy | Buy |
| 2026-01-23 | D. Boral Capital | maintain | Buy | Buy |
| 2025-10-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-27 | D. Boral Capital | maintain | Buy | Buy |
| 2025-08-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-07 | D. Boral Capital | maintain | Buy | Buy |
| 2025-07-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-07 | D. Boral Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.44 | $436.8M | 7 |
| Sun Dec 31 | $3.24 | $560.1M | 6 |
| Mon Dec 31 | $5.85 | $797.4M | 4 |
| Tue Dec 31 | $7.66 | $1.00B | 2 |